API and parent drug

Beta-Sitosterol

CAS 83-46-5 · C29H50O · 0 related records

01API identity and structure

2D structurePubChem CID 222284
2D structure: Beta-Sitosterol, CAS 83-46-5
Structure of Beta-Sitosterol (CAS 83-46-5). LazyChem record. Source identity: PubChem CID 222284. Confirm the identifiers before analytical use.Download structure image
API / medicine nameBeta-Sitosterol
CAS RN83-46-5
PubChem CID222284
Molecular formulaC29H50O
Molecular weight414.7 g/mol
IUPAC name(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Defined stereocentres9
Unassigned stereocentres0
SMILESCC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C
InChINot listed
InChIKeyKZJWDPNRJALLNS-VJSFXXLFSA-N

02Stereochemistry

The published structure contains 9 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres92D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 512Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

03Structural nitrosamine screen

Record-level resultNo candidate is published

No record-level structural candidate is currently published for this identity.

This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.

04India status for this compound

The result below applies only to this exact compound identity and CAS number.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESNo exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 83-46-5 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

06Sources